Citadel Advisors
CLMT icon

Citadel Advisors’s Calumet Specialty Products CLMT Stock Holding History

Citadel Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.48M Buy
264,100
+22,500
+9% +$583K ﹤0.01% 3334
2025
Q4 		$4.8M Sell
241,600
-16,800
-7% -$323K ﹤0.01% 4348
2025
Q3 		$4.72M Sell
258,400
-92,800
-26% -$1.53M ﹤0.01% 4467
2025
Q2 		$5.53M Buy
351,200
+20,400
+6% +$259K ﹤0.01% 3930
2025
Q1 		$4.19M Sell
330,800
-346,400
-51% -$5.44M ﹤0.01% 4171
2024
Q4 		$14.9M Buy
677,200
+79,700
+13% +$1.68M ﹤0.01% 2491
2024
Q3 		$10.6M Buy
597,500
+208,700
+54% +$3.34M ﹤0.01% 2804
2024
Q2 		$6.24M Buy
388,800
+114,200
+42% +$1.8M ﹤0.01% 3413
2024
Q1 		$4.08M Buy
274,600
+29,100
+12% +$464K ﹤0.01% 4263
2023
Q4 		$4.39M Buy
245,500
+36,900
+18% +$598K ﹤0.01% 3993
2023
Q3 		$3.98M Sell
208,600
-83,300
-29% -$1.44M ﹤0.01% 4019
2023
Q2 		$4.63M Buy
291,900
+30,300
+12% +$499K ﹤0.01% 3757
2023
Q1 		$4.55M Buy
261,600
+137,200
+110% +$2.44M ﹤0.01% 3971
2022
Q4 		$2.1M Buy
124,400
+12,600
+11% +$203K ﹤0.01% 5395
2022
Q3 		$1.43M Sell
111,800
-23,500
-17% -$337K ﹤0.01% 6241
2022
Q2 		$1.41M Buy
135,300
+50,600
+60% +$673K ﹤0.01% 6259
2022
Q1 		$1.15M Sell
84,700
-35,700
-30% -$525K ﹤0.01% 7384
2021
Q4 		$1.59M Buy
120,400
+57,900
+93% +$729K ﹤0.01% 6759
2021
Q3 		$494K Buy
62,500
+16,300
+35% +$112K ﹤0.01% 9899
2021
Q2 		$317K Sell
46,200
-6,400
-12% -$39.5K ﹤0.01% 11125
2021
Q1 		$321K Buy
52,600
+10,200
+24% +$42.6K ﹤0.01% 10689
2020
Q4 		$133K Sell
42,400
-1,700
-4% -$5.93K ﹤0.01% 10020
2020
Q3 		$112K Sell
44,100
-13,900
-24% -$35.7K ﹤0.01% 9210
2020
Q2 		$132K Buy
58,000
+32,900
+131% +$70.3K ﹤0.01% 8825
2020
Q1 		$26K Sell
25,100
-17,700
-41% -$59.8K ﹤0.01% 9232
2019
Q4 		$156K Sell
42,800
-77,900
-65% -$269K ﹤0.01% 8337
2019
Q3 		$439K Sell
120,700
-7,900
-6% -$33.8K ﹤0.01% 6962
2019
Q2 		$539K Sell
128,600
-56,200
-30% -$225K ﹤0.01% 6708
2019
Q1 		$658K Sell
184,800
-51,000
-22% -$170K ﹤0.01% 6325
2018
Q4 		$521K Buy
235,800
+76,800
+48% +$317K ﹤0.01% 6330
2018
Q3 		$1.02M Buy
159,000
+10,400
+7% +$73.8K ﹤0.01% 5511
2018
Q2 		$1.11M Sell
148,600
-11,200
-7% -$84.2K ﹤0.01% 5035
2018
Q1 		$1.13M Buy
159,800
+9,000
+6% +$66.5K ﹤0.01% 4647
2017
Q4 		$1.16M Buy
150,800
+73,600
+95% +$614K ﹤0.01% 4447
2017
Q3 		$645K Buy
77,200
+26,500
+52% +$165K ﹤0.01% 4954
2017
Q2 		$215K Buy
50,700
+31,600
+165% +$127K ﹤0.01% 6453
2017
Q1 		$73K Buy
19,100
+5,200
+37% +$20.6K ﹤0.01% 6954
2016
Q4 		$56K Buy
13,900
+3,500
+34% +$14.3K ﹤0.01% 6838
2016
Q3 		$47K Sell
10,400
-24,500
-70% -$126K ﹤0.01% 6866
2016
Q2 		$171K Sell
34,900
-1,100
-3% -$6.23K ﹤0.01% 5936
2016
Q1 		$423K Buy
36,000
+13,900
+63% +$193K ﹤0.01% 4632
2015
Q4 		$440K Buy
22,100
+17,300
+360% +$427K ﹤0.01% 4635
2015
Q3 		$117K Sell
4,800
-22,900
-83% -$595K ﹤0.01% 6804
2015
Q2 		$705K Buy
27,700
+6,500
+31% +$172K ﹤0.01% 4460
2015
Q1 		$510K Buy
21,200
+11,300
+114% +$286K ﹤0.01% 4878
2014
Q4 		$222K Sell
9,900
-4,100
-29% -$107K ﹤0.01% 5851
2014
Q3 		$384K Buy
14,000
+1,700
+14% +$51.4K ﹤0.01% 4965
2014
Q2 		$391K Sell
12,300
-16,900
-58% -$503K ﹤0.01% 4715
2014
Q1 		$755K Buy
29,200
+17,500
+150% +$478K ﹤0.01% 3788
2013
Q4 		$304K Buy
11,700
+9,100
+350% +$254K ﹤0.01% 4592
2013
Q3 		$71K Sell
2,600
-500
-16% -$15.7K ﹤0.01% 5575
2013
Q2 		$113K Buy
+3,100
New +$111K ﹤0.01% 5128

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Citadel Advisors's CLMT Position: Q1 2026 in Review

Citadel Advisors opened a new position in Calumet Specialty Products (CLMT) in Q1 2026: 536,033 shares worth $19.2M. The stake represents ﹤0.01% of the portfolio and ranks #2383 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CLMT as recently as Q3 2025.

Citadel Advisors first reported a position in CLMT in Q2 2013 and has held it in 45 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Citadel Advisors held 536,033 shares of Calumet Specialty Products worth $19.2M as of Q1 2026.
  • Calumet Specialty Products was a new Citadel Advisors position in Q1 2026.
  • Calumet Specialty Products made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2383 holding.
  • Citadel Advisors first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 45 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.